Cite
HARVARD Citation
Ducreux, M. et al. (n.d.). 2131 Efficacy and safety of nab-paclitaxel (nab-P) in patients (pts) with previously treated metastatic colorectal cancer (mCRC): The phase II COLO-001 trial. European journal of cancer. pp. S376-. [Online].